Spinal catheter insertion with extracorporeal filtration of CSF
DeviceExtracorporeal filtration of CSF
NCT Number: NCT02872636
The objective of this feasibility study is to demonstrate the safety and feasibility of using an investigational extracorporeal system and catheter to filter hemorrhagic cerebrospinal fluid (CSF) post subarachnoid hemorrhage (SAH) treatment, and reintroduce the CSF via the same catheter.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
University of Minnesota, Minneapolis, Minnesota, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Extracorporeal filtration of CSF
Time frame: 30 days
Adverse events related to the filtration procedure
Time frame: 30 days
Nerve or tissue damage related to catheter insertion
Minnetronix
Industry
Acronym: PILLAR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02894034
Brain Diseases, Cardiovascular Diseases
Amiens, France
View Trial DetailsNCT03655509
Brain Diseases, Cardiovascular Diseases
Rennes, France
View Trial DetailsNCT04042571
Brain Diseases, Cardiovascular Diseases
Bordeaux, France
View Trial DetailsNCT06797765
Brain Diseases, Cardiovascular Diseases
Dallas, Texas, United States
View Trial Details